 |
| | New peptides improve memory in mice with Alzheimer’s  Alzheimer’s disease (AD) affects over 44 million people the world over. But now, neurologist Jack Jhamandas and his team have found two short peptides which, on daily injection into mice with symptoms of AD for just five weeks, led to a significant improvement. | |
|
| | Extra virgin olive oil boosts brain power  Researchers from the Lewis Katz School of Medicine at Temple University have found that extra virgin olive oil (EVOO) could help boost brain power and help halt the progression of the effects of aging on the brain. The study was published in the latest issue of the journal Aging Cell, and it was titled, “Extra virgin olive oil improves synaptic activity, short‐term plasticity, memory, and neuropathology in a tauopathy model.” | |
|
| | New device uses electromagnetic waves to reverse Alzheimer’s  A new study, to be published in the September 3, 2019, issue of the Journal of Alzheimer's Disease, provides something to cheer about for the estimated 44 million patients who have Alzheimer’s disease (AD) in the US, and their hard-pressed caregivers. | |
|
| | Pupil dilation provides clues to future Alzheimer’s risk  Alzheimer’s disease (AD) is a progressive neurodegenerative disease that affects the quality of life of those affected by the disease. The most common form of dementia, Alzheimer’s disease negatively impacts thinking, memory, behavior. Currently, there is no cure for Alzheimer’s disease but treatments can slow its progression. | |
|
| | Does Depression and Anxiety Increase the Risk of Dementia?  Depression and anxiety can affect individuals across their life-course whereas dementia tends to typically affect older people. Depression and anxiety are common symptoms of dementia, but much less is known about whether depression and anxiety can actually lead to dementia. | |
|
|
|
.png)
No hay comentarios:
Publicar un comentario